INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 194 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,484,055 | +489.6% | 456,623 | +2006.4% | 0.01% | +200.0% |
| Q3 2019 | $1,439,000 | +92.4% | 21,678 | +266.5% | 0.00% | +200.0% |
| Q3 2018 | $748,000 | +53.9% | 5,915 | -28.9% | 0.00% | 0.0% |
| Q4 2017 | $486,000 | +1.5% | 8,315 | +0.7% | 0.00% | 0.0% |
| Q3 2017 | $479,000 | +48.8% | 8,259 | +518.2% | 0.00% | 0.0% |
| Q2 2015 | $322,000 | -38.3% | 1,336 | -27.9% | 0.00% | 0.0% |
| Q1 2015 | $522,000 | – | 1,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |